Editorial: Risk Factors and Outcome Predicating Biomarker of Neurodegenerative Diseases
Asıl Yazarlar: | Chaur-Jong Hu, Jean-Noël Octave |
---|---|
Materyal Türü: | Makale |
Dil: | English |
Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2019-02-01
|
Seri Bilgileri: | Frontiers in Neurology |
Konular: | |
Online Erişim: | https://www.frontiersin.org/article/10.3389/fneur.2019.00045/full |
Benzer Materyaller
-
Role of glucagon-like peptide-1 receptor agonists in Alzheimer’s disease and Parkinson’s disease
Yazar:: Chien-Tai Hong, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01) -
Editorial: Body fluid biomarkers in neurodegenerative studies: Novel insights into pathophysiology to support clinical practice and drug development
Yazar:: Anastasia Bougea, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01) -
Phenotype-Agnostic Molecular Subtyping of Neurodegenerative Disorders: The Cincinnati Cohort Biomarker Program (CCBP)
Yazar:: Andrea Sturchio, ve diğerleri
Baskı/Yayın Bilgisi: (2020-10-01) -
Clinical trials of new drugs for Alzheimer disease
Yazar:: Li-Kai Huang, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01) -
Current and future trends in biomarkers for the early detection of Alzheimer's disease in Asia: expert opinion
Yazar:: Kandiah, Nagaendran, ve diğerleri
Baskı/Yayın Bilgisi: (2024)